Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

STO/AZN stock hub

STO/AZN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/AZNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6T

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/AZN

In the news

Latest news · STO/AZN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.1

P25 14.9P50 22.5P75 31.5

Trailing P/E26.3

P25 17.3P50 29.9P75 44.5

ROE23.5

P25 -86.1P50 -28.3P75 4.6

ROIC16.4

P25 -52.4P50 -16.9P75 5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/AZN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	SE
Employees	96,100
Employees Change	4,400%
Employees Change Percent	4.89
Enterprise value	SEK 2.9T
Exchange	Nasdaq Stockholm
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	GB0009895292
Last refreshed	2026-05-10
Market cap	SEK 2.6T
Price	SEK 1,681
Price currency	SEK
Rev Per Employee	5,985,259.7x
Sector	Healthcare
Sic	2834
Symbol	sto/AZN
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.8%
EV Earnings	28.85x
EV/EBIT	20.1x
EV/EBITDA	14.7x
EV/FCF	26.54x
EV/Sales	4.96x
FCF yield	4.13%
Forward P/E	17.11x
P/B ratio	5.77x
P/E ratio	26.31x
P/S ratio	4.52x
PE Ratio10 Y	84.81x
PE Ratio3 Y	31.68x
PE Ratio5 Y	131.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.69%
EBITDA Margin	33.08%
FCF margin	18.68%
Gross margin	81.51%
Gross Profit	SEK 468.8B
Gross Profit Growth	8.69%
Gross Profit Growth Q	11.17%
Gross Profit Growth3 Y	10.18%
Gross Profit Growth5 Y	17.61%
Net Income	SEK 98.9B
Net Income Growth	33.67%
Net Income Growth Q	5.62%
Net Income Growth Quarters	10%
Net Income Growth Years	4%
Net Income Growth3 Y	30.22%
Net Income Growth5 Y	21.17%
Pretax Margin	21.37%
Profit Margin	17.19%
Profit Per Employee	SEK 1M
Profitable Years	36
ROA	8.47
Roa5y	5.95
ROCE	18.32
ROE	23.48
Roe5y	13.03
ROIC	16.4
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.31%
Cagr15y	15.87%
Cagr1y	27.09%
Cagr20y	11.63%
Cagr3y	5.27%
Cagr5y	15.71%
Div CAGR10	2.03%
Div CAGR3	-0.98%
Div CAGR5	4.4%
EPS Growth	33.61
EPS Growth Q	5.35
EPS Growth Quarters	10
EPS Growth Years	4
EPS Growth3 Y	30.03
EPS Growth5 Y	16.98
FCF Growth	1.26%
FCF Growth Q	-14.37%
FCF Growth3 Y	9.55%
FCF Growth5 Y	15.06%
OCF Growth	8.66%
OCF Growth Q	-9.53%
OCF Growth10 Y	11.98%
OCF Growth3 Y	13.57%
OCF Growth5 Y	16.62%
Revenue Growth	9.93x
Revenue Growth Q	12.51x
Revenue Growth Quarters	12x
Revenue Growth Years	7x
Revenue Growth3 Y	11.3x
Revenue Growth5 Y	16.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.55
Assets	SEK 1.1T
Cash	SEK 73B
Current Assets	SEK 272.9B
Current Liabilities	SEK 300.2B
Debt	SEK 323.8B
Debt EBITDA	SEK 1.67
Debt Equity	SEK 0.72
Debt FCF	SEK 3.01
Equity	SEK 450.9B
Interest Coverage	10.59
Liabilities	SEK 634.1B
Long Term Assets	SEK 812.1B
Long Term Liabilities	SEK 334B
Net Cash	SEK -250.8B
Net Cash By Market Cap	SEK -9.64
Net Debt EBITDA	SEK 1.32
Net Debt Equity	SEK 0.56
Net Debt FCF	SEK 2.33
Tangible Book Value	SEK -102.5B
Tangible Book Value Per Share	SEK -66.16
WACC	5.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	1.8
Net Working Capital	SEK -24.5B
Quick ratio	0.7
Working Capital	SEK -28.1B
Working Capital Turnover	SEK -193

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	-13.19%
Dividend Growth Years	4%
Dividend per share	SEK 29.3
Dividend Years	29
Dividend Yield	1.74%
Ex Div Date	2026-02-19
Last Dividend	SEK 19.49
Payout Frequency	Semi-Annual
Payout Ratio	46.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	393.57%
1Y total return	27.07%
200-day SMA	1,657.4
3Y total return	16.65%
50-day SMA	1,799.6
50-day SMA vs 200-day SMA	50over200
5Y total return	107.41%
All Time High	1,925.5
All Time High Change	-12.72%
All Time High Date	2026-04-08
All Time Low	210.5
All Time Low Change	698.34%
All Time Low Date	2008-03-17
ATR	38.44
Beta	0.22
Ch YTD	-1.35
High	1,688.5
High52	1,925.5
High52 Date	2026-04-10
High52ch	-12.72%
Low	1,657
Low52	1,252
Low52 Date	2025-05-12
Low52ch	34.23%
Ma50ch	-6.62%
Price vs 200-day SMA	1.39%
RSI	32.73
RSI Monthly	54.43
RSI Weekly	47.31
Sharpe ratio	0.83x
Sortino ratio	1.74
Total Return	1.82%
Tr YTD	-0.33
Tr15y	810.86%
Tr1m	-10.4%
Tr1w	-1.87%
Tr3m	-1.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 142B
Operating Income Growth	10.65
Operating Income Growth Q	17.2
Operating Income Growth3 Y	14.17
Operating Income Growth5 Y	29.99
Operating margin	24.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,543,451,508%
Net Borrowing	10,985,114,400
Shares Insiders	0.04%
Shares Institutions	68.53%
Shares Qo Q	-0.13%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 104B
Average Volume	283,673.4x
Bv Per Share	290.8
CAPEX	SEK -27.9B
Ch10y	271.1
Ch15y	432.1
Ch1m	-10.4
Ch1w	-1.87
Ch1y	24.9
Ch20y	321.7
Ch3m	-2.78
Ch3y	9.84
Ch5y	86.64
Ch6m	4.12
Change	0.06%
Change From Open	0.09
Close	1,679.5
Days Gap	-0.03
Depreciation Amortization	46,723,599,000
Dollar Volume	627,981,003.5
Earnings Date	2026-04-29
EBIT	SEK 142B
EBITDA	SEK 190.3B
EPS	SEK 63.19
F Score	7
FCF	SEK 107.5B
FCF EV Yield	3.77x
Financing CF	-43,491,593,200
Fiscal Year End	December
Founded	1,992
Goodwill	195,317,545,800
Graham Number	647.10056
Graham Upside	-61.49
Income Tax	SEK 24B
Investing CF	-69,919,635,720
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	SEK 1,352
Lynch Upside	-19.52
Ma150	1,720.9
Ma150ch	-2.35%
Ma20	1,779.6
Ma20ch	-5.57%
Net CF	21,955,165,320
Next Earnings Date	2026-07-27
Open	1,679
P FCF Ratio	24.2
P OCF Ratio	19.22
Payment Date	2026-03-23
Position In Range	74.6
Ppne	137,691,773,700
Price Date	2026-05-08
Price EBITDA	SEK 13.67
Relative Volume	1.39x
Revenue	575,183,457,640x
SBC By Revenue	0.61x
Share Based Comp	3,483,134,160
Tax By Revenue	4.17x
Tax Rate	19.52%
Tr20y	803.56%
Tr6m	5.2%
Volume	373,687
Z Score	3.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

STO/AZN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$29.3 annual per share

Payout ratio

+46.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+4.4%

4 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-02-19

Performance

STO/AZN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/AZN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+68.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

STO/AZN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.7

Neutral momentum band

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/AZN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/AZN stock rating?

sto/AZN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/AZN analysis?

The full report lives at /stocks/sto/AZN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/AZN?

The latest report frames sto/AZN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/AZN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.